CUL4A Antibody - #DF2321
製品: | CUL4A Antibody |
カタログ: | DF2321 |
タンパク質の説明: | Rabbit polyclonal antibody to CUL4A |
アプリケーション: | WB |
反応性: | Human, Mouse |
予測: | Pig, Rabbit, Dog |
分子量: | 88 kDa; 88kD(Calculated). |
ユニプロット: | Q13619 |
RRID: | AB_2839545 |
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF2321, RRID:AB_2839545.
折りたたみ/展開
2810470J21Rik; AW495282; CUL 4A; CUL-4A; Cul4a; Cul4a protein; CUL4A_HUMAN; Cullin-4A; MGC36573; MGC64071;
免疫原
- Q13619 CUL4A_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MADEAPRKGSFSALVGRTNGLTKPAALAAAPAKPGGAGGSKKLVIKNFRDRPRLPDNYTQDTWRKLHEAVRAVQSSTSIRYNLEELYQAVENLCSHKVSPMLYKQLRQACEDHVQAQILPFREDSLDSVLFLKKINTCWQDHCRQMIMIRSIFLFLDRTYVLQNSTLPSIWDMGLELFRTHIISDKMVQSKTIDGILLLIERERSGEAVDRSLLRSLLGMLSDLQVYKDSFELKFLEETNCLYAAEGQRLMQEREVPEYLNHVSKRLEEEGDRVITYLDHSTQKPLIACVEKQLLGEHLTAILQKGLDHLLDENRVPDLAQMYQLFSRVRGGQQALLQHWSEYIKTFGTAIVINPEKDKDMVQDLLDFKDKVDHVIEVCFQKNERFVNLMKESFETFINKRPNKPAELIAKHVDSKLRAGNKEATDEELERTLDKIMILFRFIHGKDVFEAFYKKDLAKRLLVGKSASVDAEKSMLSKLKHECGAAFTSKLEGMFKDMELSKDIMVHFKQHMQNQSDSGPIDLTVNILTMGYWPTYTPMEVHLTPEMIKLQEVFKAFYLGKHSGRKLQWQTTLGHAVLKAEFKEGKKEFQVSLFQTLVLLMFNEGDGFSFEEIKMATGIEDSELRRTLQSLACGKARVLIKSPKGKEVEDGDKFIFNGEFKHKLFRIKINQIQMKETVEEQVSTTERVFQDRQYQIDAAIVRIMKMRKTLGHNLLVSELYNQLKFPVKPGDLKKRIESLIDRDYMERDKDNPNQYHYVA
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q13619 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
K8 | Ubiquitination | Uniprot | |
S10 | Phosphorylation | Uniprot | |
S12 | Phosphorylation | Uniprot | |
T22 | Phosphorylation | Uniprot | |
K23 | Acetylation | Uniprot | |
K33 | Ubiquitination | Uniprot | |
S40 | Phosphorylation | Uniprot | |
K41 | Acetylation | Uniprot | |
K42 | Acetylation | Uniprot | |
S99 | Phosphorylation | Uniprot | |
K104 | Ubiquitination | Uniprot | |
K133 | Ubiquitination | Uniprot | |
S151 | Phosphorylation | Uniprot | |
Y227 | Phosphorylation | Uniprot | |
K234 | Ubiquitination | Uniprot | |
Y259 | Phosphorylation | Uniprot | |
K265 | Ubiquitination | Uniprot | |
K284 | Ubiquitination | Uniprot | |
R330 | Methylation | Uniprot | |
K357 | Ubiquitination | Uniprot | |
K359 | Ubiquitination | Uniprot | |
K369 | Ubiquitination | Uniprot | |
K391 | Ubiquitination | Uniprot | |
K404 | Ubiquitination | Uniprot | |
K411 | Ubiquitination | Uniprot | |
K416 | Ubiquitination | Uniprot | |
K422 | Acetylation | Uniprot | |
K422 | Ubiquitination | Uniprot | |
T425 | Phosphorylation | Uniprot | |
Y453 | Phosphorylation | Uniprot | |
K454 | Ubiquitination | Uniprot | |
K465 | Ubiquitination | Uniprot | |
K480 | Ubiquitination | Uniprot | |
K490 | Ubiquitination | Uniprot | |
K496 | Ubiquitination | Uniprot | |
K502 | Ubiquitination | Uniprot | |
K555 | Acetylation | Uniprot | |
K561 | Ubiquitination | Uniprot | |
C633 | S-Nitrosylation | Uniprot | |
K635 | Ubiquitination | Uniprot | |
S642 | Phosphorylation | Uniprot | |
K646 | Ubiquitination | Uniprot | |
K661 | Ubiquitination | Uniprot | |
R692 | Methylation | Uniprot | |
R702 | Methylation | Uniprot | |
K705 | Ubiquitination | Uniprot | |
K708 | Ubiquitination | Uniprot | |
K724 | Ubiquitination | Uniprot | |
K728 | Ubiquitination | Uniprot | |
K733 | Ubiquitination | Uniprot | |
S738 | Phosphorylation | Uniprot | |
R742 | Methylation | Uniprot | |
Y744 | Phosphorylation | Uniprot | |
K749 | Ubiquitination | Uniprot |
研究背景
Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination of target proteins. As a scaffold protein may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-protein ligase activity of the complex is dependent on the neddylation of the cullin subunit and is inhibited by the association of the deneddylated cullin subunit with TIP120A/CAND1. The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition component. DCX(DET1-COP1) directs ubiquitination of JUN. DCX(DDB2) directs ubiquitination of XPC. DCX(DDB2) ubiquitinates histones H3-H4 and is required for efficient histone deposition during replication-coupled (H3.1) and replication-independent (H3.3) nucleosome assembly, probably by facilitating the transfer of H3 from ASF1A/ASF1B to other chaperones involved in histone deposition. DCX(DTL) plays a role in PCNA-dependent polyubiquitination of CDT1 and MDM2-dependent ubiquitination of TP53 in response to radiation-induced DNA damage and during DNA replication. In association with DDB1 and SKP2 probably is involved in ubiquitination of CDKN1B/p27kip. Is involved in ubiquitination of HOXA9. DCX(DTL) directs autoubiquitination of DTL. The DDB1-CUL4A-DTL E3 ligase complex regulates the circadian clock function by mediating the ubiquitination and degradation of CRY1. With CUL4B, contributes to ribosome biogenesis.
Neddylated. Deneddylated via its interaction with the COP9 signalosome (CSN) complex.
(Microbial infection) Deneddylated by Epstein-Barr virus BPLF1 leading to a S-phase-like environment that is required for efficient replication of the viral genome.
Component of multiple DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complexes that seem to consist of DDB1, CUL4A or CUL4B, RBX1 and a variable substrate recognition component which seems to belong to a protein family described as DCAF (Ddb1- and Cul4-associated factor) or CDW (CUL4-DDB1-associated WD40-repeat) proteins. Component of the CSA complex (DCX(ERCC8) complex) containing ERCC8, RBX1, DDB1 and CUL4A; the CSA complex interacts with RNA polymerase II; upon UV irradiation it interacts with the COP9 signalosome and preferentially with the hyperphosphorylated form of RNA polymerase II. Component of the DCX(DET1-COP1) complex with the substrate recognition component DET1 and COP1. Component of the DCX(DDB2) complex with the substrate recognition component DDB2. Component of the DCX(DTL) complex with the putative substrate recognition component DTL. Interacts with DDB1, RBX1, RNF7, CTD1, TIP120A/CAND1, SKP2, CDKN1B, MDM2, TP53 and HOXA9. Interacts with DDB2; the interactions with DDB2 and CAND1 are mutually exclusive. Interacts with DCAF1, DTL, DDA1, DCAF6, DCAF4, DCAF16, DCAF17, DET1, WDTC1, DCAF5, DCAF11, WDR24A, COP1, PAFAH1B1, ERCC8, GRWD1, FBXW5, RBBP7, GNB2, WSB1, WSB2, NUP43, PWP1, FBXW8, ATG16L1, KATNB1, RBBP4, RBBP5, LRWD1 and DCAF8. May interact with WDR26, WDR51B, SNRNP40, WDR61, WDR76, WDR5. Can self-associate. Interacts (when neddylated) with ARIH1; leading to activate the E3 ligase activity of ARIH1. The DDB1-CUL4A complex interacts with CRY1.
(Microbial infection) Interacts with Epstein-Barr virus BPLF1.
Belongs to the cullin family.
研究領域
· Genetic Information Processing > Replication and repair > Nucleotide excision repair.
· Genetic Information Processing > Folding, sorting and degradation > Ubiquitin mediated proteolysis. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.